MTOR and Huntington disease: IGF-1, an upstream activator of the AKT-mTOR pathway, can inhibit mHtt-induced neuronal death and decrease the formation of intranuclear mHtt inclusions, via AKT phosphorylation of Htt, thereby providing a neuroprotective effect in HD (Humbert et al., 2002).